Sanofi pays $50 million for Revolution Medicines’ SHP2 inhibitor
Wednesday, July 18, 2018 - 05:10
in Psychology & Sociology
The partners expect to begin clinical studies of the compound later this year
Updated by artificial intelligence Thu, 13 Mar 2025, 3:35:01 UTC Learn more
- Tell your friends
- Get science news via